Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Chu, Van Trung Dr. (1) Daniel, Peter Prof. Dr. (2) Di Virgilio, Michela Prof. Dr. (1) Graf, Robin Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (8) Kammertöns, Thomas Dr. (4) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lewin, Gary Prof. Dr. (1) Mastrobuoni, Guido Dr. (1) Nguyen, Tam Hoai Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (14) Siffrin, Volker (1) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (4) Wanker, Erich Prof. Dr. (1) Wollert-Wulf, Brigitte (3) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zinzen, Robert Patrick Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (12) (-) Lusatis, Simone (1) (-) Mathas, Stephan Dr. (11) (-) Biologie maligner Lymphome (11) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (12) Systembiologie von Gen-regulatorischen Elementen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) 2000 (9) 2001 (6) 2002 (10) 2003 (10) (-) 2004 (10) 2005 (12) (-) 2006 (5) 2007 (8) 2008 (9) 2009 (5) 2010 (10) 2011 (9) 2012 (7) 2013 (12) 2014 (6) (-) 2015 (8) 2016 (6) 2017 (9) 2018 (5) 2019 (8) 2020 (2) 2021 (7) 2022 (10) 2023 (12) 2024 (3) 23 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Lusatis, SimoneMathas, Stephan Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200420062015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 2004 / Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken 01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 2004 / Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou